Back to discover
Disease
Presbycusis
Clinical development underwayEmerging research
1
Publications
2
Clinical trials
2020
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2020-07-20The Journal of neuroscience : the official journal of the Society for Neuroscience
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
2
0
0
2
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Leading journals1
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
Leading researchers4
- de Gruttola V1
- Liberman MC1
- O'Malley JT1
- Wu PZ1
Affiliations (unnormalised)4
- Eaton-Peabody Laboratories1
- First Affiliated Hospital1
- Harvard Medical School1
- Harvard T.H. Chan School of Public Health1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Gradual bilateral hearing loss associated with aging that is due to progressive degeneration of cochlear structures and central auditory pathways. Hearing loss usually begins with the high frequencies then progresses to sounds of middle and low frequencies.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.